3/21
08:26 am
aciu
AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts [Seeking Alpha]
Low
Report
AC Immune FY 2025 Results: Eyeing ACI-7104 Catalysts [Seeking Alpha]
3/19
07:00 am
aciu
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
High
Report
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
3/19
04:52 am
aciu
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
High
Report
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
3/16
08:03 am
aciu
AC Immune (ACIU) had its "buy" rating reaffirmed by BTIG Research. They now have a $8.00 price target on the stock.
Low
Report
AC Immune (ACIU) had its "buy" rating reaffirmed by BTIG Research. They now have a $8.00 price target on the stock.
3/13
01:01 pm
aciu
AC Immune (ACIU) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
AC Immune (ACIU) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/13
07:17 am
aciu
AC Immune GAAP EPS of -CHF0.70, revenue of CHF3.57M [Seeking Alpha]
Low
Report
AC Immune GAAP EPS of -CHF0.70, revenue of CHF3.57M [Seeking Alpha]
3/13
07:16 am
aciu
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Low
Report
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/13
07:00 am
aciu
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
Medium
Report
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
3/5
07:41 am
aciu
AC Immune Announces Upcoming Industry Symposium on Parkinson's Disease and Presentation at AD/PD™ 2026 [Yahoo! Finance]
Medium
Report
AC Immune Announces Upcoming Industry Symposium on Parkinson's Disease and Presentation at AD/PD™ 2026 [Yahoo! Finance]
3/5
07:00 am
aciu
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
Medium
Report
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
2/24
07:00 am
aciu
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
Medium
Report
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
1/8
08:13 am
aciu
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week [Yahoo! Finance]
Medium
Report
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week [Yahoo! Finance]